IL-20 targeting mAbs (Development Centre for Biotechnology)

N/A

Report date: 2025/06/11 11:13:40

Base Information

Drug NameIL-20 targeting mAbs (Development Centre for Biotechnology)

Drug Alias Nameanti-IL-20 mAbs (Development Center For Biotechnology)IL-20 targeting monoclonal antibodies (Development Centre for Biotechnology)FLB-5DCBPR-0801

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionInterleukin 20 inhibitors

TargetsInterleukin 20

Therapy Area/IndicationsInflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryTaiwan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesDevelopment Center for Biotechnology

China Registration ClassN/A

Develop Information

Active CompaniesDevelopment Center for Biotechnology

Inactive CompaniesN/A

Active IndicationsInflammation

Inactive IndicationsN/A

Other Information

ATC CodeN/A